Context: Nonalcoholic fatty liver disease (NAFLD) is increasingly diagnosed worldwide and
is the most common chronic liver disease in Western countries. In this review, we discuss the …

Nonalcoholic fatty liver disease (NAFLD) is defined as the presence of hepatic steatosis (>
5% of hepatocytes by histology or> 5.6% by nuclear magnetic resonance techniques) in the …

BACKGROUND & AIMS: To estimate the prevalence of non-alcoholic fatty liver disease
(NAFLD) in type 1 diabetic individuals, and to evaluate whether NAFLD is associated with …

Context Nonalcoholic fatty liver disease (NAFLD) prevalence is high, especially in patients
with obesity and type 2 diabetes, and is expected to rise steeply in the coming decades …

OBJECTIVE—To determine the prevalence of nonalcoholic fatty liver disease (NAFLD) in
type 2 diabetic population and to compare the prevalence of cardiovascular disease (CVD) …

Nonalcoholic fatty liver disease (NAFLD) and diabetes mellitus are common diseases that
often coexist and might act synergistically to increase the risk of hepatic and extra-hepatic …

Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of
metabolic syndrome. To date, NAFLD is the most frequent chronic liver disease seen day by …

Nonalcoholic fatty liver disease (NAFLD) is closely correlated to several metabolic syndrome
features. We assessed prospectively whether NAFLD predicts future cardiovascular disease …

Non-alcoholic fatty liver disease (NAFLD), comprising a spectrum of conditions ranging from
pure steatosis to steatohepatitis and cirrhosis, has reached epidemic proportions and …

Nonalcoholic fatty liver disease (NAFLD) is prevalent in people with the metabolic syndrome
and type 2 diabetes and is present in up to one‐third of the general population. Evidence is …